Appendix 3B - Proposed issue of securities Appendix 3B - Proposed issue of securities 1 / 5 Announcement Summary Entity name IMAGION BIOSYSTEMS LIMITED Announcement Type New announcement Date of this announcement 28/7/2026 The Proposed issue is: Total number of +securities proposed to be...
Proposed issue of securities - IBX
Filed with ASX ·
6ix hasn’t read this filing yet.
Imagion Biosystems Ltd. on 6ix
Earlier from Imagion Biosystems
- Non-Dilutive Short-Term Funding Secured
- Imagion Biosystems Secures AU$3.75M in Capital Raise Following FDA Clearance of Phase 2 Clinical Trial
- IBX Secures Firm Commitments for $3.75m for Clinical Trial
- Imagion Biosystems’ IND Application for MagSense® Phase 2 Clinical Trial Clears FDA Review
- Imagion Biosystems Receives IND Clearance from US FDA
Later from Imagion Biosystems
- Appendix 4C and Quarterly Activities Report - June 2026
- Results of General Meeting
- Application for quotation of securities - IBX
- Cleansing Notice
- Appendix 4D and Half-yearly Financial Report
Follow Imagion Biosystems into a list and get an email when it puts out news.
Follow Imagion Biosystems